The TUDCA trial--innovative trial designs for amyotrophic lateral sclerosis drugs?
Eur J Neurol
.
2016 Jan;23(1):11-2.
doi: 10.1111/ene.12691.
Epub 2015 Apr 1.
Author
A C Ludolph
1
Affiliation
1
University of Ulm, Ulm, Germany. albert.ludolph@rku.de.
PMID:
25828295
DOI:
10.1111/ene.12691
No abstract available
Publication types
Editorial
Comment
MeSH terms
Amyotrophic Lateral Sclerosis / drug therapy*
Antioxidants*
Humans
Substances
Antioxidants